Under hypoxic conditions, CAFs secrete serglycin (SRGN), which facilitates the nuclear accumulation of β-catenin in head and neck squamous cell carcinoma (HNSCC), thereby activating Wnt/β-catenin signaling and promoting cellular stemness and drug resistance (64). The gene discussed is SRGN; the disease is head and neck squamous cell carcinoma.